... treatment. After 3 weeks of hospitalization, the patients were discharged from the hospital. Both patients suffered from an aggressive COVID-19 course due to concomitant comorbidities. Conclusions: Investigating whether hormonal therapy, especially in advanced disease, acts as a protective factor or a risk...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Hormonal therapy Metastatic breast cancer Survival Targeted therapy...

...Irène Asmane; Jocelyn Céraline; Brigitte Duclos; Lynn Rob; Valère Litique; Philippe Barthélémy; Jean-Pierre Bergerat; Patrick Dufour; Jean-Emmanuel Kurtz Although advanced prostate cancer patients respond very well to front-line androgen deprivation, failure to hormonal therapy most often occurs...

...). However, duration of response and duration of survival were not significantly different for the 2 forms of hormonal therapy. Fifty-seven patients were randomised to receive second-line treatment with either medroxyprogesterone acetate (MPA), oral chlorambucil or combination chemotherapy (adriamycin...

..., instructions or products referred to in the content or advertisements. Breast carcinoma Tamoxifen Aminoglutethimide Hormonal therapy Oncology 45: 350-353 (1988) < 1988 S. Karger A G. Basel 0030 2414,88 0455 0350 S 2.75 0 Randomized Trial of Tamoxifen versus Aminoglutéthimide and versus Combined...

... survival from cyclophosphamide. The best overall results were obtained by orchiectomy alone, orchiectomy plus cyclophosphamide, and testosterone plus cyclophosphamide. Although chemotherapy alone was effective in shrinking tumor size, it was highly toxic. Prostate cancer Chemotherapy Hormonal therapy...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Case-control study Hormonal therapy Lung cancer Until recently, hormone...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Letrozole Ovarian cancer Hormonal therapy The majority of patients with epithelial ovarian cancer present...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Antiaromatase agents Breast cancer Hormonal therapy Currently raxolifene is approved for osteoporosis at 60 mg/day for the prevention of osteoporosis in postmenopausal...

... of cardiotoxicity. Therefore, studies are currently investigating Herceptin in combination with alternative anthracyclines, such as epirubicin and liposomal doxorubicin. Investigators are also beginning to examine the potential of Herceptin plus hormonal therapy, a combination that will delay the need to use...